Compendium of Cancer Genome Aberrations

DIG5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(19 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Digestive System Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Digestive System Tumours (5th Edition) Content</big>
Line 16: Line 19:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|
====CHAPTER 2 (TUMOURS OF THE OESOPHAGUS)====
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
|[[DIG5:Oesophageal_squamous_papilloma|Oesophageal squamous papilloma]]
Line 116: Line 140:
|
|
|-
|-
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
|
|Disease
====CHAPTER 3 (TUMOURS OF THE STOMACH)====
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[DIG5:Fundic_gland_polyps_|Fundic gland polyps]]
|Disease
|
|
|
|
Line 259: Line 304:
|
|
|-
|-
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
|Disease
|
|
====CHAPTER 4 (TUMOURS OF THE SMALL INTESTINE AND AMPULLA)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
|-
----<br />
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
|Disease
|
|
|
|
|
|
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
|[[DIG5:Non-ampullary_adenoma|Non-ampullary adenoma]]
|Disease
|Disease
|
|
Line 292: Line 336:
|
|
|-
|-
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
|[[DIG5:Ampullary_adenoma|Ampullary adenoma]]
|Disease
|Disease
|
|
Line 303: Line 347:
|
|
|-
|-
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
|[[DIG5:Non-ampullary_adenocarcinoma_|Non-ampullary adenocarcinoma]]
|Disease
|Disease
|
|
Line 314: Line 358:
|
|
|-
|-
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
|[[DIG5:Ampullary_adenocarcinoma_|Ampullary adenocarcinoma]]
|Disease
|Disease
|
|
Line 325: Line 369:
|
|
|-
|-
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
|[[DIG5:Small_intestinal_and_ampullary_neuroendocrine_neoplasms_|Small intestinal and ampullary neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 336: Line 380:
|
|
|-
|-
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
|Disease
|
|
====CHAPTER 5 (TUMOURS OF THE APPENDIX)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
|-
----<br />
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
|Disease
|
|
|
|
|
|
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
|[[DIG5:Appendiceal_serrated_lesions_and_polyps|Appendiceal serrated lesions and polyps]]
|Disease
|Disease
|
|
Line 369: Line 412:
|
|
|-
|-
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
|[[DIG5:Appendiceal_mucinous_neoplasm_|Appendiceal mucinous neoplasm]]
|Disease
|Disease
|
|
Line 380: Line 423:
|
|
|-
|-
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
|[[DIG5:Appendiceal_adenocarcinoma|Appendiceal adenocarcinoma]]
|Disease
|Disease
|
|
Line 391: Line 434:
|
|
|-
|-
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
|[[DIG5:Appendiceal_goblet_cell_adenocarcinoma|Appendiceal goblet cell adenocarcinoma]]
|Disease
|Disease
|
|
Line 402: Line 445:
|
|
|-
|-
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
|[[DIG5:Appendiceal_neuroendocrine_neoplasms_|Appendiceal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 413: Line 456:
|
|
|-
|-
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
|Disease
|
|
====CHAPTER 6 (TUMOURS OF THE COLON AND RECTUM)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
|[[DIG5:Colorectal_serrated_lesions_and_polyps|Colorectal serrated lesions and polyps]]
|Disease
|Disease
|
|
Line 435: Line 488:
|
|
|-
|-
|[[DIG5:Anal_condyloma|Anal condyloma]]
|[[DIG5:Conventional_colorectal_adenoma_|Conventional colorectal adenoma]]
|Disease
|Disease
|
|
Line 446: Line 499:
|
|
|-
|-
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
|[[DIG5:Inflammatory_bowel_disease-associated_dysplasia_of_the_colorectum|Inflammatory bowel disease-associated dysplasia of the colorectum]]
|Disease
|Disease
|
|
Line 457: Line 510:
|
|
|-
|-
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
|[[DIG5:Colorectal_adenocarcinoma_|Colorectal adenocarcinoma]]
|Disease
|Disease
|
|
Line 468: Line 521:
|
|
|-
|-
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
|[[DIG5:Colorectal_neuroendocrine_neoplasms_|Colorectal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 479: Line 532:
|
|
|-
|-
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
|Disease
|
|
====CHAPTER 7 (TUMOURS OF THE ANAL CANAL)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
|-
----<br />
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
|Disease
|
|
|
|
|
|
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
|[[DIG5:Inflammatory_cloacogenic_polyp|Inflammatory cloacogenic polyp]]
|Disease
|Disease
|
|
Line 512: Line 564:
|
|
|-
|-
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
|[[DIG5:Anal_condyloma|Anal condyloma]]
|Disease
|Disease
|
|
Line 523: Line 575:
|
|
|-
|-
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
|[[DIG5:Anal_squamous_dysplasia_(intraepithelial_neoplasia)|Anal squamous dysplasia (intraepithelial neoplasia)]]
|Disease
|Disease
|
|
Line 534: Line 586:
|
|
|-
|-
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
|[[DIG5:Anal_squamous_cell_carcinoma|Anal squamous cell carcinoma]]
|Disease
|Disease
|
|
Line 545: Line 597:
|
|
|-
|-
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
|[[DIG5:Anal_adenocarcinoma|Anal adenocarcinoma]]
|Disease
|Disease
|
|
Line 556: Line 608:
|
|
|-
|-
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
|[[DIG5:Anal_neuroendocrine_neoplasms|Anal neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 567: Line 619:
|
|
|-
|-
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
|Disease
|
|
====CHAPTER 8 (TUMOURS OF THE LIVER AND INTRAHEPATIC BILE DUCTS)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
|[[DIG5:Focal_nodular_hyperplasia_of_the_liver|Focal nodular hyperplasia of the liver]]
|Disease
|Disease
|
|
Line 589: Line 651:
|
|
|-
|-
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
|[[DIG5:Hepatocellular_adenoma_|Hepatocellular adenoma]]
|Disease
|Disease
|
|
Line 600: Line 662:
|
|
|-
|-
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
|[[DIG5:Hepatocellular_carcinoma|Hepatocellular carcinoma]]
|Disease
|Disease
|
|
Line 611: Line 673:
|
|
|-
|-
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
|[[DIG5:Hepatoblastoma|Hepatoblastoma]]
|Disease
|Disease
|
|
Line 622: Line 684:
|
|
|-
|-
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
|[[DIG5:Bile_duct_adenoma|Bile duct adenoma]]
|Disease
|Disease
|
|
Line 633: Line 695:
|
|
|-
|-
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
|[[DIG5:Biliary_adenofibroma|Biliary adenofibroma]]
|Disease
|Disease
|
|
Line 644: Line 706:
|
|
|-
|-
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
|[[DIG5:Mucinous_cystic_neoplasm_of_the_liver_and_biliary_system|Mucinous cystic neoplasm of the liver and biliary system]]
|Disease
|Disease
|
|
Line 655: Line 717:
|
|
|-
|-
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
|[[DIG5:Intrahepatic_cholangiocarcinoma|Intrahepatic cholangiocarcinoma]]
|Disease
|Disease
|
|
Line 666: Line 728:
|
|
|-
|-
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
|[[DIG5:Combined_hepatocellular-cholangiocarcinoma_and_undifferentiated_primary_liver_carcinoma|Combined hepatocellular-cholangiocarcinoma and undifferentiated primary liver carcinoma]]
|Disease
|Disease
|
|
Line 677: Line 739:
|
|
|-
|-
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
|[[DIG5:Hepatic_neuroendocrine_neoplasms_|Hepatic neuroendocrine neoplasms]]
|Disease
|Disease
|
|
Line 688: Line 750:
|
|
|-
|-
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
|Disease
|
|
====CHAPTER 9 (TUMOURS OF THE GALLBLADDER AND EXTRAHEPATIC BILE DUCTS)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
|[[DIG5:Pyloric_gland_adenoma_of_the_gallbladder|Pyloric gland adenoma of the gallbladder]]
|Disease
|Disease
|
|
Line 710: Line 782:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
|[[DIG5:Biliary_intraepithelial_neoplasia_|Biliary intraepithelial neoplasia]]
|Disease
|Disease
|
|
Line 721: Line 793:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
|[[DIG5:Intracholecystic_papillary_neoplasm_(formerly_Intracystic_/_intraductal_papillary_neoplasm)_|Intracholecystic papillary neoplasm (formerly Intracystic / intraductal papillary neoplasm)]]
|Disease
|Disease
|
|
Line 732: Line 804:
|
|
|-
|-
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
|[[DIG5:Intraductal_papillary_neoplasm_of_the_bile_ducts|Intraductal papillary neoplasm of the bile ducts]]
|Disease
|Disease
|
|
Line 743: Line 815:
|
|
|-
|-
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
|[[DIG5:Carcinoma_of_the_gallbladder|Carcinoma of the gallbladder]]
|Disease
|Disease
|
|
Line 754: Line 826:
|
|
|-
|-
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
|[[DIG5:Carcinoma_of_the_extrahepatic_bile_ducts|Carcinoma of the extrahepatic bile ducts]]
|Disease
|Disease
|
|
Line 765: Line 837:
|
|
|-
|-
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
|[[DIG5:Neuroendocrine_neoplasms_of_the_gallbladder_and_bile_ducts|Neuroendocrine neoplasms of the gallbladder and bile ducts]]
|Disease
|Disease
|
|
Line 776: Line 848:
|
|
|-
|-
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
|Disease
|
|
====CHAPTER 10 (TUMOURS OF THE PANCREAS)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
|[[DIG5:Acinar_cystic_transformation_of_the_pancreas|Acinar cystic transformation of the pancreas]]
|Disease
|Disease
|
|
Line 798: Line 880:
|
|
|-
|-
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
|[[DIG5:Serous_neoplasms_of_the_pancreas|Serous neoplasms of the pancreas]]
|Disease
|Disease
|
|
Line 809: Line 891:
|
|
|-
|-
|[[DIG5:Insulinoma|Insulinoma]]
|[[DIG5:Pancreatic_intraepithelial_neoplasia_|Pancreatic intraepithelial neoplasia]]
|Disease
|Disease
|
|
Line 820: Line 902:
|
|
|-
|-
|[[DIG5:Gastrinoma|Gastrinoma]]
|[[DIG5:Pancreatic_intraductal_papillary_mucinous_neoplasm_|Pancreatic intraductal papillary mucinous neoplasm]]
|Disease
|Disease
|
|
Line 831: Line 913:
|
|
|-
|-
|[[DIG5:VIPoma|VIPoma]]
|[[DIG5:Pancreatic_intraductal_oncocytic_papillary_neoplasm_|Pancreatic intraductal oncocytic papillary neoplasm]]
|Disease
|Disease
|
|
Line 842: Line 924:
|
|
|-
|-
|[[DIG5:Glucagonoma|Glucagonoma]]
|[[DIG5:Pancreatic_intraductal_tubulopapillary_neoplasm_|Pancreatic intraductal tubulopapillary neoplasm]]
|Disease
|Disease
|
|
Line 853: Line 935:
|
|
|-
|-
|[[DIG5:Somatostatinoma|Somatostatinoma]]
|[[DIG5:Pancreatic_mucinous_cystic_neoplasm_|Pancreatic mucinous cystic neoplasm]]
|Disease
|Disease
|
|
Line 864: Line 946:
|
|
|-
|-
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
|[[DIG5:Pancreatic_ductal_adenocarcinoma|Pancreatic ductal adenocarcinoma]]
|Disease
|Disease
|
|
Line 875: Line 957:
|
|
|-
|-
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
|[[DIG5:Pancreatic_acinar_cell_carcinoma|Pancreatic acinar cell carcinoma]]
|Disease
|Disease
|
|
Line 886: Line 968:
|
|
|-
|-
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
|[[DIG5:Pancreatoblastoma|Pancreatoblastoma]]
|Disease
|Disease
|
|
Line 897: Line 979:
|
|
|-
|-
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
|[[DIG5:Solid_pseudopapillary_neoplasm_of_the_pancreas|Solid pseudopapillary neoplasm of the pancreas]]
|Disease
|Disease
|
|
Line 908: Line 990:
|
|
|-
|-
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
|[[DIG5:Non-functioning_pancreatic_neuroendocrine_tumours|Non-functioning pancreatic neuroendocrine tumours]]
|Disease
|Disease
|
|
Line 919: Line 1,001:
|
|
|-
|-
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
|[[DIG5:Insulinoma|Insulinoma]]
|Disease
|Disease
|
|
Line 930: Line 1,012:
|
|
|-
|-
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
|[[DIG5:Gastrinoma|Gastrinoma]]
|Disease
|Disease
|
|
Line 941: Line 1,023:
|
|
|-
|-
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
|[[DIG5:VIPoma|VIPoma]]
|Disease
|Disease
|
|
Line 952: Line 1,034:
|
|
|-
|-
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
|[[DIG5:Glucagonoma|Glucagonoma]]
|Disease
|Disease
|
|
Line 963: Line 1,045:
|
|
|-
|-
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
|[[DIG5:Somatostatinoma|Somatostatinoma]]
|Disease
|Disease
|
|
Line 974: Line 1,056:
|
|
|-
|-
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
|[[DIG5:ACTH-producing_neuroendocrine_tumour|ACTH-producing neuroendocrine tumour]]
|Disease
|Disease
|
|
Line 985: Line 1,067:
|
|
|-
|-
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
|[[DIG5:Serotonin-producing_neuroendocrine_tumour|Serotonin-producing neuroendocrine tumour]]
|Disease
|Disease
|
|
Line 996: Line 1,078:
|
|
|-
|-
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|[[DIG5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
|Disease
|Disease
|
|
Line 1,007: Line 1,089:
|
|
|-
|-
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
|[[DIG5:Pancreatic_MiNENs|Pancreatic MiNENs]]
|Disease
|Disease
|
|
Line 1,018: Line 1,100:
|
|
|-
|-
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
|Disease
|
|
====CHAPTER 11 (HAEMATOLYMPHOID TUMOURS OF THE DIGESTIVE SYSTEM)====
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|
|
----<br />
|
|
----<br />
|
----<br />
|-
|-
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
|[[DIG5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)_involving_the_digestive_tract|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) involving the digestive tract]]
|Disease
|Disease
|
|
Line 1,040: Line 1,132:
|
|
|-
|-
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
|[[DIG5:Duodenal-type_follicular_lymphoma|Duodenal-type follicular lymphoma]]
|Disease
|Disease
|
|
Line 1,051: Line 1,143:
|
|
|-
|-
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
|[[DIG5:Enteropathy-associated_T-cell_lymphoma_|Enteropathy-associated T-cell lymphoma]]
|Disease
|Disease
|
|
Line 1,062: Line 1,154:
|
|
|-
|-
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
|[[DIG5:Monomorphic_epitheliotropic_intestinal_T-cell_lymphoma|Monomorphic epitheliotropic intestinal T-cell lymphoma]]
|Disease
|Disease
|
|
Line 1,073: Line 1,165:
|
|
|-
|-
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
|[[DIG5:Intestinal_T-cell_lymphoma_NOS|Intestinal T-cell lymphoma NOS]]
|Disease
|Disease
|
|
Line 1,084: Line 1,176:
|
|
|-
|-
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|[[DIG5:Indolent_T-cell_lymphoproliferative_disorder_of_the_GI_tract|Indolent T-cell lymphoproliferative disorder of the GI tract]]
|Disease
|Disease
|
|
Line 1,095: Line 1,187:
|
|
|-
|-
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
|[[DIG5:Hepatosplenic_T-cell_lymphoma|Hepatosplenic T-cell lymphoma]]
|Disease
|Disease
|
|
Line 1,106: Line 1,198:
|
|
|-
|-
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|[[DIG5:EBV+_inflammatory_follicular_dendritic_cell_sarcoma_of_the_digestive_tract|EBV+ inflammatory follicular dendritic cell sarcoma of the digestive tract]]
|Disease
|Disease
|
|
Line 1,117: Line 1,209:
|
|
|-
|-
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
|[[DIG5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|Disease
|
|
Line 1,128: Line 1,220:
|
|
|-
|-
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
|[[DIG5:Follicular_lymphoma|Follicular lymphoma]]
|Disease
|Disease
|
|
Line 1,139: Line 1,231:
|
|
|-
|-
|[[DIG5:Desmoid_fibromatosis_|Desmoid fibromatosis]]
|[[DIG5:Mantle_cell_lymphoma_|Mantle cell lymphoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Burkitt_lymphoma|Burkitt lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Plasmablastic_lymphoma|Plasmablastic lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Posttransplant_lymphoproliferative_disorders|Posttransplant lymphoproliferative disorders]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Extranodal_NK/T-cell_lymphoma_|Extranodal NK/T-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Systemic_mastocytosis|Systemic mastocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
====CHAPTER 12 (MESENCHYMAL TUMOURS OF THE DIGESTIVE SYSTEM)====
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|
----<br />
|-
|[[DIG5:Gastrointestinal_stromal_tumour_|Gastrointestinal stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Desmoid_fibromatosis_|Desmoid fibromatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Lipoma|Lipoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Inflammatory_fibroid_polyp|Inflammatory fibroid polyp]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Plexiform_fibromyxoma|Plexiform fibromyxoma]]
|Disease
|
|
|
|
Line 1,150: Line 1,428:
|
|
|-
|-
|[[DIG5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[DIG5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 1,161: Line 1,439:
|
|
|-
|-
|[[DIG5:Lipoma|Lipoma]]
|[[DIG5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 1,172: Line 1,450:
|
|
|-
|-
|[[DIG5:Inflammatory_fibroid_polyp|Inflammatory fibroid polyp]]
|[[DIG5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 1,183: Line 1,461:
|
|
|-
|-
|[[DIG5:Plexiform_fibromyxoma|Plexiform fibromyxoma]]
|[[DIG5:Haemangioma|Haemangioma]]
|Disease
|Disease
|
|
Line 1,194: Line 1,472:
|
|
|-
|-
|[[DIG5:Leiomyoma|Leiomyoma]]
|[[DIG5:Epithelioid_haemangioendothelioma_(prev_Vascular_Tumours_in_Liver)|Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver)]]
|Disease
|Disease
|
|
Line 1,205: Line 1,483:
|
|
|-
|-
|[[DIG5:Leiomyosarcoma|Leiomyosarcoma]]
|[[DIG5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 1,216: Line 1,494:
|
|
|-
|-
|[[DIG5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|[[DIG5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 1,227: Line 1,505:
|
|
|-
|-
|[[DIG5:Haemangioma|Haemangioma]]
|[[DIG5:Glomus_tumour_|Glomus tumour]]
|Disease
|Disease
|
|
Line 1,238: Line 1,516:
|
|
|-
|-
|[[DIG5:Epithelioid_haemangioendothelioma_(prev_Vascular_Tumours_in_Liver)|Epithelioid haemangioendothelioma (prev Vascular Tumours in Liver)]]
|[[DIG5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 1,249: Line 1,527:
|
|
|-
|-
|[[DIG5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[DIG5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 1,260: Line 1,538:
|
|
|-
|-
|[[DIG5:Angiosarcoma|Angiosarcoma]]
|[[DIG5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 1,271: Line 1,549:
|
|
|-
|-
|[[DIG5:Glomus_tumour_|Glomus tumour]]
|[[DIG5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 1,282: Line 1,560:
|
|
|-
|-
|[[DIG5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|[[DIG5:Ganglioneuroma_and_ganglioneuromatosis_|Ganglioneuroma and ganglioneuromatosis]]
|Disease
|Disease
|
|
Line 1,293: Line 1,571:
|
|
|-
|-
|[[DIG5:Schwannoma|Schwannoma]]
|[[DIG5:PEComa,_including_angiomyolipoma_|PEComa, including angiomyolipoma]]
|Disease
|Disease
|
|
Line 1,304: Line 1,582:
|
|
|-
|-
|[[DIG5:Granular_cell_tumour|Granular cell tumour]]
|[[DIG5:Mesenchymal_hamartoma_of_the_liver|Mesenchymal hamartoma of the liver]]
|Disease
|Disease
|
|
Line 1,315: Line 1,593:
|
|
|-
|-
|[[DIG5:Perineurioma|Perineurioma]]
|[[DIG5:Calcifying_nested_stromal-epithelial_tumour_of_the_liver|Calcifying nested stromal-epithelial tumour of the liver]]
|Disease
|Disease
|
|
Line 1,326: Line 1,604:
|
|
|-
|-
|[[DIG5:Ganglioneuroma_and_ganglioneuromatosis_|Ganglioneuroma and ganglioneuromatosis]]
|[[DIG5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,337: Line 1,615:
|
|
|-
|-
|[[DIG5:PEComa,_including_angiomyolipoma_|PEComa, including angiomyolipoma]]
|[[DIG5:Gastrointestinal_clear_cell_sarcoma_/_malignant_gastrointestinal_neuroectodermal_tumour|Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour]]
|Disease
|Disease
|
|
Line 1,348: Line 1,626:
|
|
|-
|-
|[[DIG5:Mesenchymal_hamartoma_of_the_liver|Mesenchymal hamartoma of the liver]]
|[[DIG5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
|Disease
|Disease
|
|
Line 1,359: Line 1,637:
|
|
|-
|-
|[[DIG5:Calcifying_nested_stromal-epithelial_tumour_of_the_liver|Calcifying nested stromal-epithelial tumour of the liver]]
|Disease
|
|
====CHAPTER 13 (OTHER TUMOURS OF THE DIGESTIVE SYSTEM)====
|
----<br />
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|
|
----<br />
|-
|-
|[[DIG5:Synovial_sarcoma|Synovial sarcoma]]
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
|Disease
|Disease
|
|
Line 1,381: Line 1,669:
|
|
|-
|-
|[[DIG5:Gastrointestinal_clear_cell_sarcoma_/_malignant_gastrointestinal_neuroectodermal_tumour|Gastrointestinal clear cell sarcoma / malignant gastrointestinal neuroectodermal tumour]]
|[[DIG5:Germ_cell_tumours_of_the_digestive_system|Germ cell tumours of the digestive system]]
|Disease
|Disease
|
|
Line 1,392: Line 1,680:
|
|
|-
|-
|[[DIG5:Embryonal_sarcoma_of_the_liver|Embryonal sarcoma of the liver]]
|[[DIG5:Digestive_system_metastases_|Digestive system metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Mucosal_melanoma_of_the_digestive_system|Mucosal melanoma of the digestive system]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[DIG5:Germ_cell_tumours_of_the_digestive_system|Germ cell tumours of the digestive system]]
|Disease
|Disease
|
|
Line 1,425: Line 1,691:
|
|
|-
|-
|[[DIG5:Digestive_system_metastases_|Digestive system metastases]]
|Disease
|
|
|
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF THE DIGESTIVE SYSTEM)====
|
|
|
|
|
|
|-
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF THE DIGESTIVE SYSTEM)
|
|
----<br />
----<br />
Line 1,458: Line 1,714:
|[[DIG5:Lynch_syndrome|Lynch syndrome]]
|[[DIG5:Lynch_syndrome|Lynch syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[DIG5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|[[DIG5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[DIG5:GAPPS_and_other_fundic_gland_polyposes|GAPPS and other fundic gland polyposes]]
|[[DIG5:GAPPS_and_other_fundic_gland_polyposes|GAPPS and other fundic gland polyposes]]
Line 1,535: Line 1,791:
|[[DIG5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|[[DIG5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[DIG5:Cowden_syndrome|Cowden syndrome]]
|[[DIG5:Cowden_syndrome|Cowden syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|Named based on DIG5 book
|Cowden syndrome included on page "[[GTS5:PTEN hamartoma tumour syndrome (PTEN)|PTEN hamartoma tumour syndrome (PTEN)]]" in GTS5 book.
|-
|-
|}
|}
Retrieved from "https://test.ccga.io/index.php/DIG5:Volunteer_Assignments_and_Opportunities"